Shield Therapeutics - Holding(s) in Company

Released

RNS Number : 5809M

Shield Therapeutics PLC
12 January 2023

 

 

TR-1: Standard form for notification of major holdings

 


NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i


 

1a.Identityoftheissuerortheunderlyingissuerofexistingsharestowhichvotingrightsareat-tachedii:

 

ShieldTherapeuticsplc

1b.Pleaseindicateiftheissuerisanon-UKissuer(pleasemarkwithan"X"ifappropriate)

UKissuer


2.Reasonforthenotification(pleasemarktheappropriateboxorboxeswithan"X")

Anacquisitionordisposalofvotingrights


Anacquisitionordisposaloffinancialinstruments


Aneventchangingthebreakdownofvotingrights

x

Other(pleasespecify)iii:


3.Detailsofpersonsubjecttothenotificationobligationiv

Name

W.HealthL.P.("Inventages")

Cityandcountryofregisteredoffice(ifapplicable)

TheBahamas

4.Fullnameofshareholder(s)(ifdifferentfrom3.)v

Name

CGWLNomineesLimited

Cityandcountryofregisteredoffice(ifapplicable)

London,UK

5.Dateonwhichthethresholdwascrossedorreachedvi:

 

6January2023

6.Dateonwhichissuernotified(DD/MM/YYYY):

11January2023

7.Totalpositionsofperson(s)subjecttothenotificationobligation


%ofvotingrightsat-tachedtoshares(to-talof8.A)

%ofvotingrightsthroughfinancialinstru-ments

(totalof8.B1+8.B2)

 

Totalofbothin%(8.A+8.B)

Totalnumberofvotingrightsheldinissuer(8.A+

8.B)vii

Resultingsituationonthedateonwhichthresholdwas

crossedorreached

 

9.56%

 

0%

 

9.56%

 

56,008,541

Positionofpreviousnotification(ifapplicable)

 

21.76%

 

0%

 

21.76%









 

 

 

 

8.Notifieddetailsoftheresultingsituationonthedateonwhichthethresholdwascrossedorreachedviii

A:Votingrightsattachedtoshares

Class/typeofshares

ISINcode(ifpossible)

Numberofvotingrightsix

%ofvotingrights

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

GB00BYV81293

56,008,541

0

9.56%

0%











SUBTOTAL8.A

56,008,541

9.56%

 

 

B1:FinancialInstrumentsaccordingtoDTR5.3.1R(1)(a)

 

Typeoffinancialin-strument

 

Expirationdatex

 

Exercise/ConversionPeriodxi

Numberofvotingrightsthatmaybeacquirediftheinstrumentisexercised/converted.

 

%ofvotingrights

















SUBTOTAL8.B1



 

 

B2:FinancialInstrumentswithsimilareconomiceffectaccordingtoDTR5.3.1R(1)(b)

Typeoffinancialinstrument

Expirationdatex

Exercise/ConversionPe-riodxi

PhysicalorcashSettlementxii

Numberofvotingrights

 

%ofvotingrights




















SUBTOTAL8.B.2



 

 

 





 

 

 

Personsubjecttothenotificationobligationisnotcontrolledbyanynaturalpersonorlegalentityanddoesnotcontrolanyotherundertaking(s)holdingdirectlyorindirectlyaninterestinthe(underlying)issuerxiii

x

Fullchainofcontrolledundertakingsthroughwhichthevotingrightsand/orthe

financialinstrumentsareeffectivelyheldstartingwiththeultimatecontrollingnaturalpersonorlegalentity(pleaseaddadditionalrowsasnecessary)xiv


 

 

Namexv

%ofvotingrightsifitequalsorishigherthanthenotifiablethreshold

%ofvotingrightsthroughfinancialin-strumentsifitequalsorishigherthanthe

notifiablethreshold

Totalofbothifitequalsorishigherthanthenotifiablethreshold


























 

 

 

10.Incaseofproxyvoting,pleaseidentify:

Nameoftheproxyholder


Thenumberand%ofvotingrightsheld


Thedateuntilwhichthevotingrightswillbeheld


 

 




 

Placeofcompletion

TheBahamas

Dateofcompletion

11January2023

 

This information is provided by RNS, the news service of the

London Stock Exchange

. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the

London Stock Exchange

use the personal data you provide us, please see our Privacy Policy.

END

HOLBTMITMTTBBJJ

Share your feedback

Discover